Drugs / BOVACTANT
BOVACTANT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02985437 | Dec 2016 → Aug 2017 | — | Prof. Dr. Dr. Ursula Mirastschijski | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BOVACTANT | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108415 ↗ |
| Known as | Alveofact | “Alveofact® (Bovine Lung Surfactant), 0.5 mg/ml per day (solution) all two days maximal eight times” NCT02985437 ↗ |
| Known as | Bovine Lung Surfactant | “Alveofact® (Bovine Lung Surfactant), 0.5 mg/ml per day (solution) all two days maximal eight times” NCT02985437 ↗ |
| Known as | SF-R11 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108415 ↗ |
| Route | Topical | “Topically Applied Bovine Lung Surfactant on Intact Skin” NCT02985437 ↗ |